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The Gynecologic Oncology Division at 
the University of Iowa consists of four 
attending physicians, three fellows-in-
training, two physician assistants, 
three nurses and supporting research 
and clerical staff. The concentration of 
our division remains the care of 
women with gynecologic malignancies. 
Our service area includes all counties 
of Iowa as well as western Illinois. Our 
patients are seen and treated in the 
National Cancer Institute designated 
Holden Comprehensive Cancer Center 
on the University of Iowa Hospitals 
campus. 
 
The clinical work of our division 
includes surgery, chemotherapy and 
radiation therapy treatments. A current 
initiative of the division is minimally 
invasive surgery in women with uterine 
cancers. This has been lead by Dr. 
David Bender who developed the 
robotic surgery program and trained 
Dr. Thomas Buekers in this 
technology. The division currently 
averages five procedures a week in 
women with gynecologic malignancies. 
A review of patient outcomes being 
assembled for publication has found 
significant decreases in patient length 
of stay and post operative 
complications with the use of robotic 
surgery. 
 
The division continues its long-
standing commitment to research 
through participation in clinical trials as 
well as a laboratory research initiative 
by Dr. Michael Goodheart. The 
division has been a member of the 
Gynecologic Oncology Group since 
shortly after its inception and 
continues to actively participate in 
trials. Our division was recently 
recognized as one of the five highest 
accruing sites among all GOG 
institutions. Dr. Goodheart is in the 
midst of a research training grant from 
the National Institutes of Health that 
allows him to divide his time between 
the clinic and laboratory. This year he 
was recognized for his work with a 
three-year, $1.5 million grant award 
from the ARRA program. 
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